In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinical trials for AML. Topics include:
- Liposomal cytarabine plus daunorubicin for secondary AML
- An overview of emerging immune-based strategies for AML
- Evidence on immune-based therapies, including agents targeting CD47, TIM3, and bispecific antibodies
Presenter:
Sarah M. Tinsley, PhD, APRN, AOCN
Nurse Practitioner
Courtesy Assistant Professor
Department of Malignant Hematology
Moffitt Cancer Center
University of South Florida
Tampa, Florida
01/10/22 • 15 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/cco-oncology-podcast-195050/strategies-for-secondary-aml-and-emerging-therapies-for-aml-18922023"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to strategies for secondary aml and emerging therapies for aml on goodpods" style="width: 225px" /> </a>
Copy